Standard
In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. / Erritzoe, David; Frøkjær, Vibe; Holst, Klaus K; Christoffersen, Maria; Johansen, Sys Stybe; Svarer, Claus; Madsen, Jacob; Rasmussen, Peter M; Ramsøy, Thomas; Jernigan, Terry L; Knudsen, Gitte M.
In:
Archives of General Psychiatry, Vol. 68, No. 6, 2011, p. 562-76.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Erritzoe, D, Frøkjær, V, Holst, KK, Christoffersen, M, Johansen, SS, Svarer, C, Madsen, J, Rasmussen, PM, Ramsøy, T, Jernigan, TL
& Knudsen, GM 2011, '
In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users',
Archives of General Psychiatry, vol. 68, no. 6, pp. 562-76.
https://doi.org/10.1001/archgenpsychiatry.2011.56APA
Erritzoe, D., Frøkjær, V., Holst, K. K., Christoffersen, M., Johansen, S. S., Svarer, C., Madsen, J., Rasmussen, P. M., Ramsøy, T., Jernigan, T. L.
, & Knudsen, G. M. (2011).
In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Archives of General Psychiatry,
68(6), 562-76.
https://doi.org/10.1001/archgenpsychiatry.2011.56Vancouver
Erritzoe D, Frøkjær V, Holst KK, Christoffersen M, Johansen SS, Svarer C et al.
In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Archives of General Psychiatry. 2011;68(6):562-76.
https://doi.org/10.1001/archgenpsychiatry.2011.56Author
Erritzoe, David ; Frøkjær, Vibe ; Holst, Klaus K ; Christoffersen, Maria ; Johansen, Sys Stybe ; Svarer, Claus ; Madsen, Jacob ; Rasmussen, Peter M ; Ramsøy, Thomas ; Jernigan, Terry L ; Knudsen, Gitte M. / In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. In: Archives of General Psychiatry. 2011 ; Vol. 68, No. 6. pp. 562-76.
Bibtex
@article{8c2dba135e324bc684d48ac220a15e70,
title = "In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or {"}ecstasy{"}) and hallucinogen users",
abstract = "Both hallucinogens and 3,4-methylenedioxymethamphetamine (MDMA or {"}ecstasy{"}) have direct agonistic effects on postsynaptic serotonin(2A) receptors, the key site for hallucinogenic actions. In addition, MDMA is a potent releaser and reuptake inhibitor of presynaptic serotonin.",
author = "David Erritzoe and Vibe Fr{\o}kj{\ae}r and Holst, {Klaus K} and Maria Christoffersen and Johansen, {Sys Stybe} and Claus Svarer and Jacob Madsen and Rasmussen, {Peter M} and Thomas Rams{\o}y and Jernigan, {Terry L} and Knudsen, {Gitte M}",
year = "2011",
doi = "http://dx.doi.org/10.1001/archgenpsychiatry.2011.56",
language = "English",
volume = "68",
pages = "562--76",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "The JAMA Network",
number = "6",
}
RIS
TY - JOUR
T1 - In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users
AU - Erritzoe, David
AU - Frøkjær, Vibe
AU - Holst, Klaus K
AU - Christoffersen, Maria
AU - Johansen, Sys Stybe
AU - Svarer, Claus
AU - Madsen, Jacob
AU - Rasmussen, Peter M
AU - Ramsøy, Thomas
AU - Jernigan, Terry L
AU - Knudsen, Gitte M
PY - 2011
Y1 - 2011
N2 - Both hallucinogens and 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") have direct agonistic effects on postsynaptic serotonin(2A) receptors, the key site for hallucinogenic actions. In addition, MDMA is a potent releaser and reuptake inhibitor of presynaptic serotonin.
AB - Both hallucinogens and 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") have direct agonistic effects on postsynaptic serotonin(2A) receptors, the key site for hallucinogenic actions. In addition, MDMA is a potent releaser and reuptake inhibitor of presynaptic serotonin.
U2 - http://dx.doi.org/10.1001/archgenpsychiatry.2011.56
DO - http://dx.doi.org/10.1001/archgenpsychiatry.2011.56
M3 - Journal article
VL - 68
SP - 562
EP - 576
JO - JAMA Psychiatry
JF - JAMA Psychiatry
SN - 2168-622X
IS - 6
ER -
